Episode summary
$10.5 Trillion Reports This Week. The AI Trade Has to Deliver | Mon Oct 26 Live Trading
Summary
The morning show framed the week as a major macro event cluster, with roughly one-third of the S&P 500 reporting, the Fed meeting, ECB and Bank of Japan decisions, and GDP and PCE all on deck. The host and guests argued that Monday’s bounce in stocks may matter less than what happens after Wednesday’s Fed decision and the big tech earnings, especially Microsoft and Alphabet. They emphasized that the market is still digesting last week’s volatility and that index-level conviction should wait until later in the week.
A big early theme was AI and its second-order effects. Gus highlighted Elon Musk’s tweet warning that “200 plus Neoclouds” face consolidation, which knocked down CoreWeave, Nebius, and other GPU-as-a-service names. The discussion then broadened into whether companies will eventually buy their own GPUs instead of renting cloud capacity, and whether the AI infrastructure trade is getting ahead of itself.
The group also focused on Tesla, with Barclays upgrading the stock on robo-taxi potential, a SpaceX merger angle, and core business strength. They contrasted that with the continued slide in FICO after Wells Fargo’s downgrade, arguing that AI is eroding the company’s moat and that the stock may be in a structural repricing. Moderna was another focal point, with the guest calling the post-leak selloff a buying opportunity because the leaked melanoma vaccine data sounded bullish despite the disclosure issue.
Key takeaways
- The host said this week is dominated by earnings, the Fed, ECB, BOJ, GDP, and PCE, so index moves before Wednesday may be less meaningful.
- Gus said Elon Musk’s tweet about “200 plus Neoclouds” helped push CoreWeave, Nebius, and similar AI infrastructure names lower.
- The host and Gus were bullish on Tesla after Barclays’ overweight upgrade, citing robo-taxi growth and a possible SpaceX merger angle.
- The host argued FICO looks structurally challenged as AI makes its credit-score business easier to replicate and less valuable.
- The guest stayed long Moderna, saying the leaked melanoma vaccine data was bullish even though the leak itself pressured the stock.
Notable quotes
“we have a really busy week coming up. We're seeing a sort of a relief bid right now in the market”
“200 plus Neoclouds are going to see quote Guppy level death end quote in consolidation”
“this business is going away. I don't know. I don't know that for sure but it seems like it”
“despite the fact that the information leaked was actually very bullish information, but everybody is is concerned about the nature of how we came into this information”
Topics
- ai trading
- weekly market reports
- stock market outlook
- pre-market and opening bell
- risk and reward strategies
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Tastylive
-
Nvidia Is Down 37% and Traders Can’t Agree What Happens Next -
Tim Knight Calls This the Great Sell-the-News Event -
Tim Knight Says Earnings Are Done, Data Is Done, and Nothing’s Left to Move It -
There's No Single Volatility Number for a Stock -
Markets Grind Higher and Crash Lower, and Here's the Proof -
NVIDIA SHOCK: Jensen Huang RESIGNS; NVDA -9% | THURSDAY Nov 12 Live Trading
Tastylive, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.